http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0336958-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-217 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-17 |
| filingDate | 1988-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1992-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1992-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0336958-B1 |
| titleOfInvention | Product containing as active principles: a) a peptide having an activity of the type of that of human gamma interferon, b) hydroxyurea |
| abstract | The invention relates to a product containing as active principles: a) a peptide having an activity of the type of that of human gamma interferon, b) hydroxyurea, for the treatment of chronical myeloide leucemia and related syndromes. |
| priorityDate | 1987-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 33.